Micro-pulse Transscleral Laser Therapy and ‘Topical-plus’ Anaesthesia: Ideal for Glaucoma Management During COVID-19
US Ophthalmic Review
; 15(2):50-54, 2021.
Article
in English
| EMBASE | ID: covidwho-1737463
ABSTRACT
Micro-pulse transscleral laser therapy (MP-TLT) is a non-invasive laser procedure for the treatment of glaucoma, and was introduced in 2015. The aim of the procedure is to achieve a reduction in intraocular pressure while minimizing collateral tissue damage. The favourable risk profile of this non-cyclodestructive procedure makes it applicable to a broad spectrum of glaucoma cases, including patients with good central vision, and does not limit its usability to late-stage refractive cases. In 2019, a revised delivery device simplified the procedure, and more recently, a ‘topical-plus’ anaesthesia protocol has been introduced. The revised delivery system and topical-plus protocol reinforce the utility of MP-TLT as a practical treatment option in an office setting or procedure room, with minimal patient discomfort during and after treatment. Additionally, with minimal follow-up requirements, MP-TLT is ideal for glaucoma management during COVID-19 social restrictions. The following article provides an overview of the use of MP-TLT under topical anaesthesia (topicalplus), the potential role of MP-TLT in the glaucoma treatment algorithm during the COVID-19 pandemic, and the advantages of the revised MicroPulse P3® probe (IRIDEX Corporation, Mountain View, CA, USA).
laser; MicroPulse P3; operating room; ophthalmic speculum; brimonidine; dexamethasone sodium phosphate; fentanyl; phenylephrine; prednisolone acetate; propofol; thiopental; anesthesia; article; clinical practice; conjunctival hemorrhage; consultation; coronavirus disease 2019; disease control; follow up; glaucoma; health care access; health care utilization; health service; human; infection risk; intraocular pressure; laser therapy; lockdown; micro pulse transscleral laser therapy; nonhuman; outpatient; palpebral fissure; pandemic; patient care; patient safety; phacoemulsification; postoperative care; practice guideline; prescription; prospective study; randomized controlled trial (topic); refraction error; retrobulbar anesthesia; risk factor; Severe acute respiratory syndrome coronavirus 2; sleep time; Switzerland; therapy effect; tissue injury; travel restriction; treatment duration; treatment outcome; vision; visual acuity; vitrectomy
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
US Ophthalmic Review
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS